<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23712" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Diabetes Intraoperative Management</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kaur</surname>
            <given-names>Kimpreet</given-names>
          </name>
          <aff>SAMMC</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anastasopoulou</surname>
            <given-names>Catherine</given-names>
          </name>
          <aff>Jefferson Einstein Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Joyner</surname>
            <given-names>Robert W.</given-names>
          </name>
          <aff>Brooke Army Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kimpreet Kaur declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Catherine Anastasopoulou declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Robert Joyner declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23712.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>According to Centers for Disease Control data, the incidence of diabetes mellitus in the United States in 2015 was 30.3 million and is predicted to increase yearly with an already prediabetic population of 84 million. The prevalence of diabetes is highest in the Alaska Native and Native American populations, followed by African Americans, Hispanics, Asians, and Whites. Diabetes can cause a lot of complications, not only in the long run but also during acute hyperglycemic events. It has been found that hyperglycemia during surgical interventions may impair the healing process, increase infections, and lengthen hospital stays. Overall morbidity and mortality can increase by 50%, necessitating tight glycemic control during operations. This activity reviews the intraoperative management of diabetes and highlights the interprofessional team's role in managing patients with diabetes mellitus.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications for intraoperative management of diabetes.</p></list-item><list-item><p>Assess the complications of unregulated hyperglycemia during surgery.</p></list-item><list-item><p>Determine the clinical benefits of regulating blood glucose during surgery.</p></list-item><list-item><p>Strategize with the interprofessional team to improve&#x000a0;care coordination and&#x000a0;patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23712&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23712">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23712.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>According to Centers for Disease Control data, the incidence of diabetes mellitus in&#x000a0;the&#x000a0;United States in 2015 was 30.3 million&#x000a0;and is predicted to increase yearly with an already prediabetic population of 84 million.<xref ref-type="bibr" rid="article-23712.r1">[1]</xref>&#x000a0;The prevalence of diabetes is highest in the Alaska&#x000a0;Native&#x000a0;and Native American populations, followed by African Americans, Hispanics, Asians, and Whites.<xref ref-type="bibr" rid="article-23712.r1">[1]</xref>&#x000a0; There are different types of diabetes mellitus described in the latest American Diabetes Association (ADA) classification, but the two most commonly seen are type 1 diabetes and type 2 diabetes.[2]</p>
        <p>Type 1 diabetes is an immune-mediated destruction of the insulin-producing beta cells in the pancreas. Due to this insulin deficiency, individuals with type 1 diabetes must rely on lifelong exogenous insulin administration to maintain normal blood glucose levels. Often referred to in the past as juvenile diabetes, type 1 diabetes typically manifests in younger individuals, commonly being diagnosed during childhood, teenage years, or early adulthood.&#x000a0;Many times, the diagnosis of type 1 diabetes&#x000a0;is made when a patient is admitted to the hospital for diabetic ketoacidosis, a life-threatening condition characterized by hyperglycemia, metabolic acidosis, and ketosis.<xref ref-type="bibr" rid="article-23712.r2">[2]</xref></p>
        <p>Type 2 diabetes, once known as adult-onset diabetes, was traditionally seen in older individuals. However, due to rising obesity rates, type 2 diabetes now affects a broad age range, from children to older individuals. Type 2 diabetes arises either from peripheral insulin resistance or a reduction in insulin secretion. Although the exact mechanism is not universally agreed upon, it's hypothesized that increased intracellular fatty acid metabolites may activate a serine kinase cascade, impairing insulin signaling.<xref ref-type="bibr" rid="article-23712.r1">[1]</xref> Typically, by the time of diagnosis, more than 60% of pancreatic beta cells may have lost their function.<xref ref-type="bibr" rid="article-23712.r3">[3]</xref> Complete beta cell destruction may occur as the disease progresses, necessitating reliance on exogenous insulin. Initially, type 2 diabetes is typically managed with oral hypoglycemic agents and lifestyle modifications. Studies have demonstrated that caloric restriction and weight loss can improve glycemic control.<xref ref-type="bibr" rid="article-23712.r4">[4]</xref></p>
      </sec>
      <sec id="article-23712.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Surgery and acute illness are stressors that alter homeostasis and lead to hyperglycemia. Stress conditions raise counter-regulatory hormones such as glucagon, epinephrine, cortisol, and growth hormone. This process leads to insulin&#x000a0;resistance, increased hepatic glucose production, impaired peripheral glucose utilization, and relative insulin deficiency.<xref ref-type="bibr" rid="article-23712.r5">[5]</xref></p>
        <p>Epinephrine stimulates glucagon secretion and inhibits insulin secretion by the pancreatic beta cells.<xref ref-type="bibr" rid="article-23712.r6">[6]</xref> Additionally, the increased level of stress hormones leads to enhanced lipolysis and high free fatty acid (FFA) concentrations. Increased FFA correlates with&#x000a0;inhibiting insulin-stimulated glucose uptake&#x000a0;and limits the intracellular signaling cascade in skeletal muscle responsible for glucose transport activity.<xref ref-type="bibr" rid="article-23712.r5">[5]</xref></p>
        <p>Hyperglycemia leads to the release of pro-inflammatory&#x000a0;cytokines such as tumor necrosis factor-alpha, interleukin 6, and interleukin 1B.<xref ref-type="bibr" rid="article-23712.r7">[7]</xref> In addition, hyperglycemia has also been shown to impair leukocyte function, phagocytosis, chemotaxis, and bacterial destruction.<xref ref-type="bibr" rid="article-23712.r8">[8]</xref>&#x000a0;Increased reactive oxygen species due to hyperglycemia can result in direct cellular damage and further impair the vascular and immune systems.&#x000a0;This oxidative stress contributes&#x000a0;to increased platelet aggregation&#x000a0;and a prothrombotic state.<xref ref-type="bibr" rid="article-23712.r9">[9]</xref></p>
      </sec>
      <sec id="article-23712.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Diagnosis of diabetes is made when a patient meets one of the following criteria:</p>
        <list list-type="bullet">
          <list-item>
            <p>A glucose level equal to, or greater than, 126 mg/dL after fasting for at least 8 hours</p>
          </list-item>
          <list-item>
            <p>Random venous plasma glucose equal to, or greater than, 200 mg/dL&#x000a0;in a patient with classic symptoms of hyperglycemia</p>
          </list-item>
          <list-item>
            <p>Plasma glucose equal to, or greater than, 200 mg/dL&#x000a0;measured two hours after a glucose load of&#x000a0;75 g during an oral glucose tolerance test</p>
          </list-item>
          <list-item>
            <p>Hemoglobin A<sub>1C</sub> equal to, or greater than, 6.5%&#x000a0;<xref ref-type="bibr" rid="article-23712.r10">[10]</xref>&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23712.s5" sec-type="Equipment">
        <title>Equipment</title>
        <p>Intraoperative management of diabetes requires access to the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Alaris pump and tubing&#x000a0;</p>
          </list-item>
          <list-item>
            <p>100 mL bag of normal saline</p>
          </list-item>
          <list-item>
            <p>Insulin&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Point of care glucose testing strips (alternative arterial line or venous blood gas analysis)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>50% dextrose&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23712.s6" sec-type="Personnel">
        <title>Personnel</title>
        <p>Different providers may be involved in the overall care of patients with diabetes, from primary care providers to specialists like endocrinologists who manage diabetes regularly. When a patient is scheduled for a surgical procedure, all providers contributing to everyday patient care should be involved in preparing the patient before the operation. Instructions can be provided by the provider who knows the patient the best and would feel comfortable giving the appropriate advice for the patient to get ready for the surgery. In most cases, the surgical team should reach out to the patient's medical team and ask for advice to optimize the patient's diabetes status. The anesthesia team responsible for the surgical procedure should also try to reach out and obtain accurate information on&#x000a0;the patient's outpatient treatments to decide the best approach for perioperative glycemic control.</p>
      </sec>
      <sec id="article-23712.s7" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>There are no strict guidelines for canceling a surgical case due to hyperglycemia. The Society for Ambulatory Anesthesia (SAMBA) recommends canceling a case if a patient is experiencing diabetic ketoacidosis, hyperglycemic hyperosmolar nonketotic state, or severe dehydration.<xref ref-type="bibr" rid="article-23712.r11">[11]</xref></p>
        <p>On the day of surgery, if a patient has a blood sugar over 140 mg/dL, blood glucose should be monitored every 2 hours intraoperatively with a point of care glucose via arterial line or venous blood from a peripheral intravenous line.</p>
        <p>If a patient has a blood glucose level greater than or equal to 180 mg/dL and is critically ill, an intravenous insulin drip should be initiated.<xref ref-type="bibr" rid="article-23712.r12">[12]</xref>&#x000a0;The starting dose of the insulin drip (units/hour) can be calculated with blood glucose/100 and titrated according to Table 1.<xref ref-type="bibr" rid="article-23712.r5">[5]</xref> The half-life of insulin is 35 minutes, so it is titrated easily, and blood sugar monitoring should occur hourly.</p>
        <p>For those who are not critically ill and have a short procedure (less than 4 hours), which does not usually anticipate large fluid shifts, it is preferable to use rapid-acting subcutaneous (SC) insulin. Table 2 below gives guidance on how to dose SC insulin on the day of surgery for those who are insulin sensitive (no history of diabetes), those who are insulin resistant (total daily dose (TDD) of insulin&#x000a0;exceeding 80 units, BMI greater than 35, prednisone dose greater than 20 mg), and whose who require usual amounts of insulin (all other categories).<xref ref-type="bibr" rid="article-23712.r5">[5]</xref></p>
      </sec>
      <sec id="article-23712.s8" sec-type="Complications">
        <title>Complications</title>
        <p>Control of&#x000a0;hyperglycemia intraoperatively is of great importance because there is a 50% increase in morbidity and mortality in&#x000a0;patients with diabetes mellitus compared to patients without diabetes mellitus.<xref ref-type="bibr" rid="article-23712.r13">[13]</xref></p>
        <p>Research correlates perioperative hyperglycemia&#x000a0;with increased hospital and intensive care unit length of stay, poor healing progression<xref ref-type="bibr" rid="article-23712.r14">[14]</xref>, and higher numbers of postoperative cases of pneumonia, systemic blood infection, urinary tract infection, acute renal failure, and acute myocardial infarction.<xref ref-type="bibr" rid="article-23712.r13">[13]</xref></p>
        <p>Hypokalemia&#x000a0;is an&#x000a0;associated complication of hyperglycemia treatment&#x000a0;with insulin, especially with coinciding diabetic ketoacidosis. Insulin drives potassium extracellular and hydrogen ions intracellular. Excess potassium is lost in urine&#x000a0;due to osmotic diuresis. Other derangements include hypocalcemia, hypomagnesemia, and QT prolongation.<xref ref-type="bibr" rid="article-23712.r15">[15]</xref></p>
        <p>Other life-threatening&#x000a0;complications of insulin use include hypoglycemia. Those treated with tight glycemic control were five times more likely to experience severe hypoglycemia (blood glucose less than 40 mg/dL) postoperatively in comparison to liberal glucose treatment.<xref ref-type="bibr" rid="article-23712.r16">[16]</xref> Symptoms of hypoglycemia&#x000a0;include tremors, sweating, dizziness, light-headedness, seizures, and loss of consciousness. Intraoperatively hypoglycemia can cause a delay in emergence&#x000a0;from anesthesia&#x000a0;until&#x000a0;exogenous glucose is administered to normalize blood sugar.<xref ref-type="bibr" rid="article-23712.r17">[17]</xref></p>
      </sec>
      <sec id="article-23712.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>There is no&#x000a0;agreement among the anesthesiology community on the standard of care for blood&#x000a0;glucose&#x000a0;levels. However, there is a consensus on aiming for blood glucose levels&#x000a0;below&#x000a0;180 mg/dL, as more aggressive goals may cause hypoglycemia. Recent metanalysis revealed that there is no difference in mortality in patients treated&#x000a0;with very tight glucose control (blood glucose &#x0003c;110 mg/dL), tight glucose control (111-150 mg/dL), and liberal blood glucose control&#x000a0;(blood glucose &#x0003c;220 mg/dL).<xref ref-type="bibr" rid="article-23712.r16">[16]</xref> There was a decrease in adverse events&#x000a0;in the tight glucose control group for surgical site infection, acute kidney injury, sepsis, and atrial fibrillation.</p>
      </sec>
      <sec id="article-23712.s10" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Each institution should develop a standardized protocol for hyperglycemia to be used in the preoperative area, intraoperative, and postanesthesia care units to ensure optimal perioperative glucose control. Communication amongst an interprofessional group is necessary as surgeons, anesthesiologists, intensivists, internal medicine providers, endocrinologists, pharmacists, and nurses are usually closely involved in patient care. Most patients will come from the main floor or the intensive care unit, so there should be a good handoff.</p>
        <p>After the operation, prioritizing optimal communication among the care teams is crucial for the patient's recovery. This approach ensures continuity of care until the patient fully recovers. If any complications or adverse effects arise, they should be promptly addressed in a multidisciplinary team approach. Any changes in the patient's diabetes management must be communicated to their primary care physicians or endocrinologists. These healthcare providers will follow up with the patient to adjust medications or implement other measures for maintaining optimal diabetes control at all times.&#x000a0;An interprofessional team&#x000a0;strategy is critical in preventing long-term complications associated with diabetes.</p>
      </sec>
      <sec id="article-23712.s11" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>Before undergoing surgery, patients need to consult with their regular healthcare providers (eg, primary care physicians, nurse practitioners, or endocrinologists) who manage their diabetes. This consultation will allow patients to tailor their diabetes management for the upcoming procedure. Intraoperatively, the anesthesia team assumes responsibility for diabetes treatment decisions. The anesthesia team should provide a detailed account of the diabetes management during the surgery to the healthcare team caring for the patients postoperatively. This continuity of care&#x000a0;will ensure there are no gaps in diabetes management, from surgery to full recovery and eventual discharge from the hospital.</p>
      </sec>
      <sec id="article-23712.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23712&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23712">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23712/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23712">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-23712.s13">
        <fig id="article-23712.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Intraoperative Diabetes Management Tables Contributed by Kimpreet Kaur, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="intraoperative__diabetic__management__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-23712.s14">
        <title>References</title>
        <ref id="article-23712.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saini</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Molecular mechanisms of insulin resistance in type 2 diabetes mellitus.</article-title>
            <source>World J Diabetes</source>
            <year>2010</year>
            <month>Jul</month>
            <day>15</day>
            <volume>1</volume>
            <issue>3</issue>
            <fpage>68</fpage>
            <page-range>68-75</page-range>
            <pub-id pub-id-type="pmid">21537430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glaser</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fritsch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Priyambada</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rewers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cherubini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Estrada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wolfsdorf</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Codner</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state.</article-title>
            <source>Pediatr Diabetes</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>7</issue>
            <fpage>835</fpage>
            <page-range>835-856</page-range>
            <pub-id pub-id-type="pmid">36250645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cerf</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Beta cell dysfunction and insulin resistance.</article-title>
            <source>Front Endocrinol (Lausanne)</source>
            <year>2013</year>
            <volume>4</volume>
            <fpage>37</fpage>
            <pub-id pub-id-type="pmid">23542897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henry</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Scheaffer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Olefsky</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1985</year>
            <month>Nov</month>
            <volume>61</volume>
            <issue>5</issue>
            <fpage>917</fpage>
            <page-range>917-25</page-range>
            <pub-id pub-id-type="pmid">4044780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duggan</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Perioperative Hyperglycemia Management: An Update.</article-title>
            <source>Anesthesiology</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>126</volume>
            <issue>3</issue>
            <fpage>547</fpage>
            <page-range>547-560</page-range>
            <pub-id pub-id-type="pmid">28121636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonnell</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Insulin therapy for the management of hyperglycemia in hospitalized patients.</article-title>
            <source>Endocrinol Metab Clin North Am</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>175</fpage>
            <page-range>175-201</page-range>
            <pub-id pub-id-type="pmid">22575413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hotamisligil</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Choy</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Spiegelman</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Tumor necrosis factor alpha inhibits signaling from the insulin receptor.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1994</year>
            <month>May</month>
            <day>24</day>
            <volume>91</volume>
            <issue>11</issue>
            <fpage>4854</fpage>
            <page-range>4854-8</page-range>
            <pub-id pub-id-type="pmid">8197147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delamaire</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maugendre</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Le Goff</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Allannic</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Genetet</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Impaired leucocyte functions in diabetic patients.</article-title>
            <source>Diabet Med</source>
            <year>1997</year>
            <month>Jan</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-34</page-range>
            <pub-id pub-id-type="pmid">9017350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamagishi</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Edelstein</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>XL</given-names>
              </name>
              <name>
                <surname>Brownlee</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction.</article-title>
            <source>Diabetes</source>
            <year>2001</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>1491</fpage>
            <page-range>1491-4</page-range>
            <pub-id pub-id-type="pmid">11375352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <collab>American Diabetes Association</collab>
            <article-title>2. Classification and Diagnosis of Diabetes: <italic>Standards of Medical Care in Diabetes-2018</italic>.</article-title>
            <source>Diabetes Care</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>Suppl 1</issue>
            <fpage>S13</fpage>
            <page-range>S13-S27</page-range>
            <pub-id pub-id-type="pmid">29222373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joshi</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vann</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gan</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Goulson</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Merrill</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Twersky</surname>
                <given-names>R</given-names>
              </name>
              <collab>Society for Ambulatory Anesthesia</collab>
            </person-group>
            <article-title>Society for Ambulatory Anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery.</article-title>
            <source>Anesth Analg</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>111</volume>
            <issue>6</issue>
            <fpage>1378</fpage>
            <page-range>1378-87</page-range>
            <pub-id pub-id-type="pmid">20889933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duggan</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Klopman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The Emory University Perioperative Algorithm for the Management of Hyperglycemia and Diabetes in Non-cardiac Surgery Patients.</article-title>
            <source>Curr Diab Rep</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>34</fpage>
            <pub-id pub-id-type="pmid">26971119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frisch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Smiley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gatcliffe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hudson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mendoza</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery.</article-title>
            <source>Diabetes Care</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>33</volume>
            <issue>8</issue>
            <fpage>1783</fpage>
            <page-range>1783-8</page-range>
            <pub-id pub-id-type="pmid">20435798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lucke-Wold</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Diabetes management in spinal surgery.</article-title>
            <source>J Clin Images Med Case Rep</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>3</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">35795240</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johansen</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>A Systematic Review on Insulin Overdose Cases: Clinical Course, Complications and Treatment Options.</article-title>
            <source>Basic Clin Pharmacol Toxicol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>122</volume>
            <issue>6</issue>
            <fpage>650</fpage>
            <page-range>650-659</page-range>
            <pub-id pub-id-type="pmid">29316226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>ZQ</given-names>
              </name>
              <name>
                <surname>Huo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Zhai</surname>
                <given-names>XJ</given-names>
              </name>
            </person-group>
            <article-title>Effects of perioperative tight glycemic control on postoperative outcomes: a meta-analysis.</article-title>
            <source>Endocr Connect</source>
            <year>2018</year>
            <month>Dec</month>
            <day>01</day>
            <volume>7</volume>
            <issue>12</issue>
            <fpage>R316</fpage>
            <page-range>R316-R327</page-range>
            <pub-id pub-id-type="pmid">30120204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23712.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misal</surname>
                <given-names>US</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Shaikh</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Delayed recovery from anesthesia: A postgraduate educational review.</article-title>
            <source>Anesth Essays Res</source>
            <year>2016</year>
            <season>May-Aug</season>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>164</fpage>
            <page-range>164-72</page-range>
            <pub-id pub-id-type="pmid">27212741</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
